Literature DB >> 9457609

Aerobic, anaerobic and fungal burn wound infections.

H A Mousa1.   

Abstract

One hundred and twenty-seven patients were studied prospectively for aerobic, anaerobic and fungal burn wound infections. All cases yielded organisms on culture. A total of 377 isolates were recovered (239 aerobes, 116 anaerobes and 22 fungi). Aerobic bacteria alone were present in 49 patients (38.6%). Anaerobic bacteria alone were present in four patients (3.2%). Candida sp. alone was present in one patient (0.8%). Mixed aerobic and/or anaerobic bacteria and/or fungi were present in 73 patients (57.5%). Fungi were isolated from 21 patients (23.9%) of 88 patients having fungal cultures. The predominant isolates recovered in descending order of frequency were: Pseudomonas aeruginosa, Staphylococcus aureus, Bacteroides sp., Klebsiella sp. and Peptostreptococcus sp. There were 70 patients (55.1%) infected with anaerobic bacteria. The rate of recovery of anaerobes was higher in patients with open wound dressing (72.7%) than in patients with occlusive wound dressings (41.7%), (P < 0.01). Seventeen patients presented with septic shock, 15 of them (88.2%) yielding positive anaerobic cultures. Bacteroides sp. were isolated from 14 patients with septic shock, and were recovered from the four patients who had anaerobic infection alone. These results indicate a significant role of Bacteroides sp. in burn wound sepsis.

Entities:  

Mesh:

Year:  1997        PMID: 9457609     DOI: 10.1016/s0195-6701(97)90148-1

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  21 in total

Review 1.  Wound microbiology and associated approaches to wound management.

Authors:  P G Bowler; B I Duerden; D G Armstrong
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 2.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

3.  Modification of dienes mutual inhibition test for epidemiological characterization of Pseudomonas aeruginosa isolates.

Authors:  Erik L Munson; Michael A Pfaller; Gary V Doern
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Nosocomial infections among burn patients in Teheran, Iran: a decade later.

Authors:  R Alaghehbandan; L Azimi; A Rastegar Lari
Journal:  Ann Burns Fire Disasters       Date:  2012-03-31

Review 5.  Epidemiology of burn injuries in the East Mediterranean Region: a systematic review.

Authors:  Nasih Othman; Denise Kendrick
Journal:  BMC Public Health       Date:  2010-02-20       Impact factor: 3.295

6.  Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p.

Authors:  Brian M Peters; Ekaterina S Ovchinnikova; Bastiaan P Krom; Lisa Marie Schlecht; Han Zhou; Lois L Hoyer; Henk J Busscher; Henny C van der Mei; Mary Ann Jabra-Rizk; Mark E Shirtliff
Journal:  Microbiology       Date:  2012-08-23       Impact factor: 2.777

7.  Prevalence of bacterial pathogens in infected wounds in a tertiary hospital, 1995-2001: any change in trend?

Authors:  Lateef O A Thanni; Olubunmi A Osinupebi; Mope Deji-Agboola
Journal:  J Natl Med Assoc       Date:  2003-12       Impact factor: 1.798

8.  Epidemiology and outcome of burns at the Saud Al Babtain Burns, Plastic Surgery and Reconstructive Center, Kuwait: our experience over five years (from 2006 to 2010).

Authors:  H A Khashaba; A N Al-Fadhli; K S Al-Tarrah; Y T Wilson; N Moiemen
Journal:  Ann Burns Fire Disasters       Date:  2012-12-31

9.  Pseudomonas aeruginosa PAO1 pyocin production affects population dynamics within mixed-culture biofilms.

Authors:  Richard D Waite; Michael A Curtis
Journal:  J Bacteriol       Date:  2008-12-05       Impact factor: 3.490

10.  Fungal colonisation in burn wounds: An Indian scenerio.

Authors:  Navin Kumar Goyal; Madhuri A Gore; R S Goyal
Journal:  Indian J Surg       Date:  2010-02-05       Impact factor: 0.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.